These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 27841100

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.
    Eitah HE, Maklad YA, Abdelkader NF, Gamal El Din AA, Badawi MA, Kenawy SA.
    Toxicol Appl Pharmacol; 2019 Feb 15; 365():30-40. PubMed ID: 30576699
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protective effect of dipeptidyl peptidase-4 inhibitors in testicular torsion/detorsion in rats: a possible role of HIF-1α and nitric oxide.
    Abdelzaher WY, Rofaeil RR, Ali DME, Attya ME.
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr 15; 393(4):603-614. PubMed ID: 31773182
    [Abstract] [Full Text] [Related]

  • 8. The dipeptidyl peptidase-4 inhibitor sitagliptin ameliorates renal injury in type 1 diabetic mice via inhibiting the TGF-β/Smad signal pathway.
    Li L, Lian X, Wang Z, Zheng J, Liu J, Chu Y, Teng Y, Zhang Z.
    Pharmazie; 2019 Apr 01; 74(4):239-242. PubMed ID: 30940309
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM, El-Edel RH, Harisa GE, El-Halawany N, Ghonaim MM.
    Pak J Pharm Sci; 2009 Apr 01; 22(2):205-10. PubMed ID: 19339234
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats.
    Rauscher FM, Sanders RA, Watkins JB.
    J Biochem Mol Toxicol; 2001 Apr 01; 15(1):41-6. PubMed ID: 11170314
    [Abstract] [Full Text] [Related]

  • 15. Sitagliptin ameliorates diabetic nephropathy by upregulating renal nephrin and podocin expression through modulation of adipokines levels.
    Ashraf A, Akhtar T, Shabbir A, Aftab U, Shahzad M.
    Fundam Clin Pharmacol; 2023 Jun 01; 37(3):549-555. PubMed ID: 36594370
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
    Ahmed OM, Ali TM, Abdel Gaid MA, Elberry AA.
    PLoS One; 2019 Jun 01; 14(9):e0214349. PubMed ID: 31527864
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renoprotective effect of Hypericum perforatum against diabetic nephropathy in rats: Insights in the underlying mechanisms.
    Abd El Motteleb DM, Abd El Aleem DI.
    Clin Exp Pharmacol Physiol; 2017 Apr 01; 44(4):509-521. PubMed ID: 28079268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.